Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML

Introduction: Despite a 50% cure rate, relapse remains the main cause of death in patients with acute myeloid leukemia (AML) consolidated with autologous stem cell transplantation (ASCT) in first remission (CR1). Clonal hematopoiesis of indeterminate potential (CH) increases the risk for hematologic...

Full description

Bibliographic Details
Main Authors: Alexander D. Heini, Naomi Porret, Reinhard Zenhaeusern, Annette Winkler, Ulrike Bacher, Thomas Pabst
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
acute myeloid leukemia (AML)
autologous stem cell transplantation (ASCT)
clonal hematopoiesis (CH)
prognosis
outcome
Online Access:https://www.mdpi.com/2072-6694/13/13/3190

Similar Items

Similar Items